Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page
Demo Data from SIGIR 2026 / reviewers in the wild / expert

Lionel Colliandre

dblp:43/11478 · DBLP profile ↗
← Back
1ranked-venue papers
0as first author
0since 2021 · last 2012
0009-0006-1035-3696ORCID · reported

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 1

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 100%

Topics — the 4 heaviest of 5, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology › molecular informatics
cheminformatics		 0.112012
e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design · Bioinform. 2012
Bioinformatics and computational biology
drug discovery		 0.112012
e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design · Bioinform. 2012
Bioinformatics and computational biology › drug discovery
drug repurposing		 0.112012
e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design · Bioinform. 2012
Bioinformatics and computational biology › drug discovery › drug design
fragment-based drug design		 0.112012
e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design · Bioinform. 2012

Methods — techniques the papers use, named apart from their topics

in silico screening · 0.1
YearPublicationVenuePosition
2012 e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design
abstract
Abstract Motivation: In the drug discovery field, new uses for old drugs, selective optimization of side activities and fragment-based drug design (FBDD) have proved to be successful alternatives to high-throughput screening. e-Drug3D is a database of 3D chemical structures of drugs that provides several collections of ready-to-screen SD files of drugs and commercial drug fragments. They are natural inputs in studies dedicated to drug repurposing and FBDD. Availability: e-Drug3D collections are freely available at http://chemoinfo.ipmc.cnrs.fr/e-drug3d.html either for download or for direct in silico web-based screenings. Contact: [email protected] Supplementary information: Supplementary data are available at Bioinformatics online.
Emilie Pihan, Lionel Colliandre, Jean-François Guichou, Dominique Douguet
 Bioinform.2